Epidermal inoculation of Leishmania-antigen by gold bombardment results in a chronic form of leishmaniasis

Vaccine

Volumn 25, Issue 1, 2007, Pages 25-33

  Weiss, Richard ^a   Scheiblhofer, Sandra ^a   Thalhamer, Josef ^a   Bickert, Thomas ^b   Richardt, Ulrike ^b   Fleischer, Bernhard ^b   Ritter, Uwe ^b  

^a UNIVERSITY OF SALZBURG   (Austria)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Epidermal antigen inoculation; Gene gun; Gold particles; T cell response

Indexed keywords

ANTIGEN; GOLD; LEISHMANIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; DENDRITIC CELL; FEMALE; GENE GUN IMMUNIZATION; IMMUNOMODULATION; INOCULATION; LEISHMANIA; LEISHMANIASIS; MOUSE; NONHUMAN; PARASITE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

ANIMALS; ANTIGENS, PROTOZOAN; BIOLISTICS; CHRONIC DISEASE; EPIDERMIS; FEMALE; LANGERHANS CELLS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; TH1 CELLS;

EID: 33845198325     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.07.044     Document Type: Article

References (43)

1. Ritter U., Moll H., Laskay T., et al. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis 173 3 (1996) 699-709
2. Pearson R.D., Wheeler D.A., Harrison L.H., and Kay H.D. The immunobiology of leishmaniasis. Rev Infect Dis 5 5 (1983) 907-927
3. Ritter U., Meissner A., Scheidig C., and Korner H. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur J Immunol 34 6 (2004) 1542-1550
4. Belkaid Y., Von Stebut E., Mendez S., et al. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J Immunol 168 8 (2002) 3992-4000
5. Sacks D., and Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2 11 (2002) 845-858
6. Alexander J., and Bryson K. T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol Lett 99 1 (2005) 17-23
7. Moll H., Fuchs H., Blank C., and Rollinghoff M. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur J Immunol 23 7 (1993) 1595-1601
8. Valladeau J., Clair-Moninot V., Dezutter-Dambuyant C., et al. Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J Immunol 168 2 (2002) 782-792
9. Anjuere F., Martin P., Ferrero I., et al. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood 93 2 (1999) 590-598
10. Misslitz A.C., Bonhagen K., Harbecke D., Lippuner C., Kamradt T., and Aebischer T. Two waves of antigen-containing dendritic cells in vivo in experimental Leishmania major infection. Eur J Immunol 34 3 (2004) 715-725
11. Kissenpfennig A., Henri S., Dubois B., et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22 5 (2005) 643-654
12. Stoitzner P., Tripp C.H., Douillard P., Saeland S., and Romani N. Migratory Langerhans cells in mouse lymph nodes in steady-state and inflammation. J Invest Dermatol 125 1 (2005) 116-125
13. Mayerova D., Parke E.A., Bursch L.S., Odumade O.A., and Hogquist K.A. Langerhans cells activate naïve self-antigen-specific CD8 T cells in the steady-state. Immunity 21 3 (2004) 391-400
14. Woods G.M., Chen Y.P., Dewar A.L., Doherty K.V., Toh B.H., and Muller H.K. Prevention of autoimmunity by induction of cutaneous tolerance. Cell Immunol 207 1 (2001) 1-5
15. Steinman R.M., and Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 99 1 (2002) 351-358
16. Probst H.C., Lagnel J., Kollias G., and van den Broek M. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 18 5 (2003) 713-720
17. Tang D.C., DeVit M., and Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 356 6365 (1992) 152-154
18. Bennett A.M., Phillpotts R.J., Perkins S.D., Jacobs S.C., and Williamson E.D. Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus. Vaccine 18 7-8 (1999) 588-596
19. Lodmell D.L., Ray N.B., Ulrich J.T., and Ewalt L.C. DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL). Vaccine 18 11-12 (2000) 1059-1066
20. Weiss R., Leitner W.W., Scheiblhofer S., et al. Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein. Infect Immun 68 10 (2000) 5914-5919
21. Yoshida A., Nagata T., Uchijima M., Higashi T., and Koide Y. Advantage of gene gun mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses. Vaccine 18 17 (2000) 1725-1729
22. Feltquate D.M., Heaney S., Webster R.G., and Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 158 5 (1997) 2278-2284
23. Oran A.E., and Robinson H.L. DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells. J Immunol 171 4 (2003) 1999-2005
24. Barry M.A., and Johnston S.A. Biological features of genetic immunization. Vaccine 15 8 (1997) 788-791
25. Weiss R., Scheiblhofer S., Freund J., Ferreira F., Livey I., and Thalhamer J. Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 20 25-26 (2002) 3148-3154
26. Chen D., and Payne L.G. Targeting epidermal Langerhans cells by epidermal powder immunization. Cell Res 12 2 (2002) 97-104
27. Chen D., Endres R.L., Erickson C.A., et al. Epidermal immunization by a needle-free powder delivery technology: immunogenicity of influenza vaccine and protection in mice. Nat Med 6 10 (2000) 1187-1190
28. Maddelein M.L., Dos Reis S., Duvezin-Caubet S., Coulary-Salin B., and Saupe S.J. Amyloid aggregates of the HET-s prion protein are infectious. Proc Natl Acad Sci USA 99 11 (2002) 7402-7407
29. Solbach W., Forberg K., Kammerer E., Bogdan C., and Rollinghoff M. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice. J Immunol 137 2 (1986) 702-707
30. Schulz A., Mellenthin K., Schonian G., Fleischer B., and Drosten C. Detection, differentiation, and quantitation of pathogenic leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay. J Clin Microbiol 41 4 (2003) 1529-1535
31. Wilhelm P., Ritter U., Labbow S., et al. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J Immunol 166 6 (2001) 4012-4019
32. Siegmund K., Feuerer M., Siewert C., et al. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106 9 (2005) 3097-3104
33. Rhee E.G., Mendez S., Shah J.A., et al. Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection. J Exp Med 195 12 (2002) 1565-1573
34. Brown D.R., and Reiner S.L. Polarized helper-T-cell responses against Leishmania major in the absence of B cells. Infect Immun 67 1 (1999) 266-270
35. Finkelman F.D., Holmes J., Katona I.M., et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 8 (1990) 303-333
36. Glaser R., Harder J., Lange H., Bartels J., Christophers E., and Schroder J.M. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 6 1 (2005) 57-64
37. Moll H., Ritter U., Flohe S., Erb K., Bauer C., and Blank C. Cutaneous leishmaniasis: a model for analysis of the immunoregulation by accessory cells. Med Microbiol Immunol (Berl) 184 4 (1996) 163-168
38. Ritter U., and Osterloh A. A new view on cutaneous dendritic cell subsets in experimental leishmaniasis. Med Microbiol Immunol (Berl) (2006)
39. Kaplan D.H., Jenison M.C., Saeland S., Shlomchik W.D., and Shlomchik M.J. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23 6 (2005) 611-620
40. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., and von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6 12 (2005) 1219-1227
41. Itano A.A., and Jenkins M.K. Antigen presentation to naïve CD4 T cells in the lymph node. Nat Immunol 4 8 (2003) 733-739
42. Wilson N.S., El-Sukkari D., Belz G.T., et al. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102 6 (2003) 2187-2194
43. Bogdan C., Rollinghoff M., and Diefenbach A. The role of nitric oxide in innate immunity. Immunol Rev 173 (2000) 17-26